Sign in
4

Changes in Ownership

Kalaris Therapeutics, Inc. Filed Acc 0000899243-22-035893

Chief Commercial Officer sold 36,592 shares at $8.20 ($299,904)

From the SEC's structured data for this filing

Trades in this filing

VAN BEEK JEROEN B · Chief Commercial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-11-11 Sale : show line 1 in the form −36,592 $8.20 $299,904 349,800 D
Open-market sales · 36,592 sh · avg $8.20 · $299,904
Loading xslF345X03/doc4.xml…